Live Quote · NASDAQBRTXHealthcare· Biotechnology

BioRestorative Therapies, Inc.

$0.40 3.73%(+$0.01)
TickerSpark Score
47/100
Weak
53
Valuation
40
Profitability
10
Growth
84
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BRTX research report →

52-Week Range14% of range
Low
$0.16
Current
$0.40
High
$1.89
Company Overviewwww.biorestorative.com

About the company

BioRestorative Therapies, Inc. is a life sciences company dedicated to developing regenerative medicine products and therapies. Their approach primarily utilizes adult stem cell protocols to address two key areas: disc/spine disease and metabolic disorders.

CEO
Lance Alstodt
IPO
2012
Employees
11
HQ
Melville, NY, US

Price Chart

-74.84% · this period
$1.84$1.00$0.17Jul 02Dec 31Jul 02
Valuation
Market Cap
$3.60M
P/E
-0.33
P/S
10.05
P/B
1.19
EV/EBITDA
-0.05
Div Yield
0.00%
Profitability
Gross Margin
92.09%
Op Margin
-3975.00%
Net Margin
-3089.55%
ROE
-423.84%
ROIC
-464.86%
Growth & Income
Revenue
$359.70K · -10.30%
Net Income
$-14,241,975 · -58.61%
EPS
$-1.58 · -36.21%
Op Income
$-15,647,132
FCF YoY
-30.81%
Performance & Tape
52W High
$1.89
52W Low
$0.16
50D MA
$0.31
200D MA
$0.80
Beta
0.64
Avg Volume
10.61M

Get TickerSpark's AI analysis on BRTX

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 10, 26Grasso Mikaother0
Jun 10, 26Dhaliwal Jatinderother0
Jun 10, 26Field Katharynother0
Oct 6, 25Silva Franciscoother11,719
Oct 6, 25Silva Franciscoother11,719
Oct 6, 25ALSTODT LANCEother15,625
Oct 6, 25ALSTODT LANCEother11,719
Feb 14, 25Rosa David Aother52,632
Feb 14, 25Williams Patrick F.other52,632
Feb 14, 25Kukekov Nickolay V.other52,632
Coverage · BRTX

Our BRTX coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on BRTX yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate BRTX report →
Internal Compare

Similar companies

Peers in the same neighborhood.